Skip to main content
. 2020 Apr 16;14:1507–1521. doi: 10.2147/DDDT.S224857

Table 5.

Suspected Adverse Drug Reactions During the Study Period

Adverse Drug Reaction Total (N=3170) Active Cohort (n=2679) Passive Cohort (n=491)
na IRb na IRb na IRb
Total 548 173.0 384 143.0 164 334.0
 No serious (top 20) 544 172.0 383 143.0 161 328.0
  Anorexia 109 34.4 76 28.4 33 67.2
  General weakness 87 27.4 58 21.6 29 59.1
  Cough 76 24.0 50 18.7 26 53.0
  Vomiting 47 14.8 24 9.0 6 12.2
  Dizziness 37 11.7 26 9.7 11 22.4
  Diarrhea 36 11.4 30 11.2 23 46.8
  Abdominal pain 36 11.4 22 8.2 14 28.5
  Pruritus 14 4.4 12 4.5 2 4.1
  Nausea 14 4.4 7 2.6 2 4.1
  Fever 13 4.1 11 4.1 0 0.0
  Rhinitis 9 2.8 9 3.4 0 0.0
  Somnolence 9 2.8 5 1.9 7 14.3
  Insomnia 7 2.2 7 2.6 0 0.0
  Muscle/joint pain 6 1.9 6 2.2 4 8.1
  Headache 6 1.9 4 1.5 0 0.0
  Tinnitus 5 1.6 3 1.1 0 0.0
  Anemia 4 1.3 4 1.5 2 4.1
  Epigastric pain 4 1.3 4 1.5 0 0.0
  Dermatosis 3 0.9 3 1.1 2 4.1
  Chest pain 2 0.6 2 0.7 0 0.0
 Serious 4 1.3 1 0.4 3 6.11
  Gastroenteritis 1 0.3 0 0 1 2.0
  Convulsion 1 0.3 1 0.4 0 0
  Dizziness 1 0.3 0 0 1 2.0
  General weakness 1 0.3 0 0 1 2.0

Notes: aIndicates the number of events; a patient could have one or more events at a time. bIndicates the incidence rate per 1000 (n/N).